SCHEMBL3749321

SCHEMBL3749321

COc1cc(C)c(Cl)c(C)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.53
CYP3A4 P08684 3/20 0.48
CHRM1 P11229 1/20 0.48
ALOX15 P16050 1/20 0.48
MAOA P21397 1/20 0.48
TBXA2R P21731 1/20 0.48
ADRA1A P35348 1/20 0.48
HTR2B P41595 1/20 0.48
MCL1 Q07820 1/20 0.44
FFAR4 Q5NUL3 2/20 0.42
TSHR P16473 2/20 0.41
POLB P06746 2/20 0.41
OGG1 O15527 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41
HPGD P15428 2/20 0.41
CYP1A1 P04798 1/20 0.40
CYP1B1 Q16678 1/20 0.40
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16958899 0.87 ALDH1A1 (0.46) ALDH1A1CYP3A4CHRM1ALOX15MAOA
SCHEMBL11185624 0.87 PTPN1 (0.50) ALDH1A1CYP3A4CHRM1ALOX15MAOA
SCHEMBL18523730 0.85 ALDH1A1 (0.43) ALDH1A1CYP3A4CHRM1ALOX15MAOA
SCHEMBL1133298 0.85 ALDH1A1 (0.45) ALDH1A1CYP3A4FFAR4POLBCYP1A2
SCHEMBL16009653 0.84 ALDH1A1 (0.44) ALDH1A1CYP3A4FFAR4POLBCYP1A2
SCHEMBL16134065 0.84 ALDH1A1 (0.42) ALDH1A1CYP3A4CHRM1ALOX15MAOA
SCHEMBL7627906 0.80 ALDH1A1 (0.40) ALDH1A1CYP3A4MCL1FFAR4TSHR
SCHEMBL17522141 0.80 FKBP1A (0.45) ALDH1A1CYP3A4FFAR4TSHRPOLB
SCHEMBL11177610 0.79 KDM4E (0.42) ALDH1A1CYP3A4CHRM1ALOX15MAOA
SCHEMBL9847949 0.77 ALDH1A1 (0.46) ALDH1A1CYP3A4FFAR4TSHRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104327106-A Preparation method of high-sterically-hindered arylborate compound SHENZHEN RES INST THE HONG KONG POLYTECHNIC UNIVERSITY 2015-02-04 CN claimed
US-20220396549-A1 SMALL MOLECULE INHIBITORS OF THE MCL-1 ONCOPROTEIN AND USES THEROF UNIV MARYLAND (US) 2022-12-15 US disclosed
WO-2022253713-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN CAPTOR THERAPEUTICS S.A. (PL) 2022-12-08 WO disclosed
EP-3319938-B1 SMALL MOLECULE INHIBITORS OF THE MCL-1 ONCOPROTEIN AND USES THEREOF UNIV MARYLAND (US) 2022-04-06 EP disclosed
US-10858316-B2 Small molecule inhibitors of the MCL-1 oncoprotein and uses thereof UNIVERSITY OF MARYLAND, BALTIMORE (US) 2020-12-08 US disclosed
US-20180208554-A1 Small Molecule Inhibitors of the MCL-1 Oncoprotein and Uses Thereof UNIVERSITY OF MARYLAND, BALTIMORE 2018-07-26 US disclosed
US-20180208554-A1 Small Molecule Inhibitors of the MCL-1 Oncoprotein and Uses Thereof UNIVERSITY OF MARYLAND, BALTIMORE 2018-07-26 US disclosed
WO-2017011323-A1 SMALL MOLECULE INHIBITORS OF THE MCL-1 ONCOPROTEIN AND USES THEREOF UNIVERSITY OF MARYLAND, BALTIMORE (US) 2017-01-19 WO disclosed
US-20160194279-A1 ONE POT PROCESS FOR THE CONVERSION OF AROYL CHLORIDES TO ACYL THIOUREAS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-07-07 US disclosed
US-20160194279-A1 ONE POT PROCESS FOR THE CONVERSION OF AROYL CHLORIDES TO ACYL THIOUREAS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-07-07 US disclosed
US-20100304966-A1 Fungicidal Compounds, Method For the Production Thereof, And Use Thereof To Combat Damaging Fungi, And Agents Comprising The Same BASF SE (DE) 2010-12-02 US disclosed
US-7161022-B2 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative FUJIFILM FINECHEMICALS CO., LTD. (JP) 2007-01-09 US disclosed
US-7161022-B2 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative FUJIFILM FINECHEMICALS CO., LTD. (JP) 2007-01-09 US disclosed
US-20050250846-A1 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use ANDERSON MARK B 2005-11-10 US disclosed
EP-1560818-A1 NON-PEPTIDE GNRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USE PFIZER INC. (US) 2005-08-10 EP disclosed
US-6903132-B2 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use AGOURON PHARMACEUTICALS, INC. (US) 2005-06-07 US disclosed
US-20040014787-A1 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use AGOURON PHARMACEUTICALS, INC. 2004-01-22 US disclosed
WO-2003106446-A1 NON-PEPTIDE GNRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USE PFIZER INC. (US) 2003-12-24 WO disclosed
EP-0088346-B1 2-AMINOMETHYL-PHENOL DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HOECHST AKTIENGESELLSCHAFT (DE) 1985-06-05 EP disclosed
EP-0088346-A2 2-Aminomethyl-phenol derivatives, process for their preparation, their use and pharmaceutical compositions containing them HOECHST AKTIENGESELLSCHAFT (DE) 1983-09-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050250846-A1 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use GNRHR, LHCGR, FSHR ALDH1A1 4773/4885CYP3A4 2533/4885CHRM1 4636/4885
US-20220396549-A1 SMALL MOLECULE INHIBITORS OF THE MCL-1 ONCOPROTEIN AND USES THEROF MCL1, TP53, MYC ALDH1A1 2903/4885CYP3A4 4789/4885CHRM1 4880/4885
US-20040014787-A1 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use GNRHR, LHCGR, FSHR ALDH1A1 4773/4885CYP3A4 2533/4885CHRM1 4636/4885
US-10858316-B2 Small molecule inhibitors of the MCL-1 oncoprotein and uses thereof MCL1, BCL3, BCL9 ALDH1A1 2863/4885CYP3A4 4773/4885CHRM1 4881/4885
US-20180208554-A1 Small Molecule Inhibitors of the MCL-1 Oncoprotein and Uses Thereof MCL1, BCL3, BCL9 ALDH1A1 2863/4885CYP3A4 4773/4885CHRM1 4881/4885
US-20160194279-A1 ONE POT PROCESS FOR THE CONVERSION OF AROYL CHLORIDES TO ACYL THIOUREAS TRRAP, NAT1, AHR ALDH1A1 445/4885CYP3A4 167/4885CHRM1 3479/4885
US-20100304966-A1 Fungicidal Compounds, Method For the Production Thereof, And Use Thereof To Combat Damaging Fungi, And Agents Comprising The Same CYP51A1, ERG28, CAT ALDH1A1 651/4885CYP3A4 55/4885CHRM1 4151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.